<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40748">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02575911</url>
  </required_header>
  <id_info>
    <org_study_id>CTJ121-P001</org_study_id>
    <nct_id>NCT02575911</nct_id>
  </id_info>
  <brief_title>Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study</brief_title>
  <official_title>Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the thickness accuracy of Laser-assisted in situ
      keratomileusis (LASIK) flaps created with the LenSx® Laser.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flap thickness accuracy within the central zone at Month 3 postoperative</measure>
    <time_frame>Month 3 postoperative</time_frame>
    <description>Flap accuracy is defined as mean flap thickness minus desired flap thickness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Flap thickness accuracy within the central zone at Month 1 postoperative</measure>
    <time_frame>Month 1 postoperative</time_frame>
    <description>Flap accuracy is defined as mean flap thickness minus desired flap thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flap thickness precision within the central zone at Month 1 and Month 3 postoperative</measure>
    <time_frame>Up to Month 3 postoperative</time_frame>
    <description>Flap accuracy precision (variability of the achieved flap thickness) is defined as the standard deviation of the flap thickness measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of flap dissection at Day 0, operative day</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>Ease of flap dissection will be assessed on a scale from 0 to 5 where 0 = Unable to lift flap and 5 = Able to lift flap without any resistance using blunt instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stromal bed quality at Day 0, operative day</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>Stromal bed quality will be assessed on a scale from 0 to 5 where 0 = Very rough and 5 = Very smooth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opaque Bubble Layer (OBL) at Day 0, operative day</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>Opaque bubble layer will be assessed on a scale from 0 to 5 where 0 = No opaque bubble layer and 5 = 100% stromal bed area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected Distance Visual Acuity (UCDVA) at Month 1 and Month 3 postoperative</measure>
    <time_frame>Up to Month 3 postoperative</time_frame>
    <description>Distance visual acuity will be assessed unaided using a standard Snellen eye chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best corrected distance visual acuity (BCDVA) Baseline, Month 1 postoperative, and Month 3 postoperative</measure>
    <time_frame>Up to Month 3 postoperative</time_frame>
    <description>Distance visual acuity will be assessed with the participant's best spectacle correction using a standard Snellen eye chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manifest Refraction at Baseline, Month 1 postoperative, and Month 3 postoperative</measure>
    <time_frame>Up to Month 3 postoperative</time_frame>
    <description>The subject will be manually refracted to his/her best correction using a phoropter and standard Snellen eye charts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction error between target vs achieved refraction at Month 1 and Month 3 postoperative</measure>
    <time_frame>Up to Month 3 postoperative</time_frame>
    <description>Prediction error is defined as target refraction minus achieved refraction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <arm_group>
    <arm_group_label>LenSx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LASIK surgery in both eyes using LenSx® Femtosecond Laser System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond Laser System</intervention_name>
    <description>Used for the creation of a corneal flap in patients undergoing LASIK surgery</description>
    <arm_group_label>LenSx</arm_group_label>
    <other_name>LenSx®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK surgery</intervention_name>
    <arm_group_label>LenSx</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with myopia or hyperopia and eligible for femtosecond laser initiated LASIK
             surgery;

          -  Best corrected visual acuity (BCVA) correctable to at least 20/25 in each eye;

          -  If contact lens wearer, willing to discontinue contact lens wear prior to screening
             procedures;

          -  Willing and able to return for ALL scheduled follow-up examinations;

          -  Willing and able to provide written informed consent;

          -  Eligible for bilateral LASIK procedures to be done on the same day;

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Previous corneal surgery, corneal lesions that will impede laser treatment, corneal
             edema, hypotony, glaucoma, existing corneal implant, or keratoconus;

          -  Known sensitivity to planned study concomitant medications;

          -  Participation in any other ophthalmic drug or device clinical study for 30 days prior
             to or during the time of participation in this study;

          -  Irregular astigmatism, based on the Investigator's judgement;

          -  Pregnant, lactating or planning to become pregnant during the course of the study;

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Manager, GMA, Surgical</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 28, 2016</lastchanged_date>
  <firstreceived_date>October 13, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
